FAZA PET/MRI Pancreas
Feasibility Study of Hypoxia and Re-oxygenation Imaging in Pancreatic Cancer Using Positron Emission Tomography (PET) With [18F] Fluoroazomycin-arabinoside (FAZA PET) and Magnetic Resonance Imaging (MRI)
Sponsor: University Health Network, Toronto
A NA clinical study on Locally Advanced Pancreatic Adenocarcinoma and Pancreatic Adenocarcinoma Non-resectable, this trial is ongoing. The trial is conducted by University Health Network, Toronto and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Mar 2026 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2022 — May 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
-
Nov 2021 — Feb 2022 [monthly]
Recruiting NA
-
Jun 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .